Saxenda® is contraindicated in patients with a private or relatives historical past of MTC and in clients with Various Endocrine Neoplasia syndrome type two (MEN two). Counsel people regarding the likely risk of MTC with utilization of Saxenda® and notify them of signs and symptoms of thyroid tumors (eg, a mass inside the neck, dysphagia, dyspn